XD14
XD14 is a potent BET inhibitor with antitumor effect. It binds to BRD2, BRD3, and BRD4 with Kds of 170, 380, and 160 nM, respectively[1].
Product Specifications
CAS Number
[1370888-71-3]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/xd14.html
Purity
95.00
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
O=C(C1=C(CC)C(C(C)=O)=C(C)N1)NC2=CC(S(=O)(N(CC)CC)=O)=CC=C2O
Molecular Formula
C20H27N3O5S
Molecular Weight
421.51
Precautions
H302, H315, H319, H335
References & Citations
[1]Schäker-Hübner L, et al. 4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug Leads. J Med Chem. 2021 Oct 14;64 (19) :14620-14646.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BRD2; BRD3; BRD4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
38631124 3x 1.0µg DNA
RBM39 CRISPRa sgRNA lentivector (set of three targets)(Mouse)
Ask
View Details 
EK344316 96 Well
Porcine CKLFSF4 (Chemokine Like Factor Superfamily 4) ValidElisa Kit
Ask
View Details